SCHEMBL6132881

SCHEMBL6132881

CC(=O)N1CC(=O)N/C(=C/c2cc3ccccc3[nH]2)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
HRH3 Q9Y5N1 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
CYP2A6 P11509 1/20 0.40
MAOB P27338 2/20 0.39
ATP6V1B1 P15313 1/20 0.37
PRF1 P14222 1/20 0.36
AMY1A P0DUB6 1/20 0.36
MAPT P10636 2/20 0.35
IDO1 P14902 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
KDM4E B2RXH2 2/20 0.35
TSHR P16473 1/20 0.35
NT5E P21589 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132883 1.00 MEN1 (0.56) MEN1KMT2AHRH3SIRT1CYP2A6
SCHEMBL7362683 0.77 MEN1 (0.66) MEN1KMT2AHRH3MAPTNPSR1
SCHEMBL79547 0.77 MEN1 (0.66) MEN1KMT2AHRH3MAPTNPSR1
SCHEMBL1598877 0.77 MEN1 (0.66) MEN1KMT2AHRH3MAPTNPSR1
SCHEMBL12096519 0.74 MEN1 (0.56) MEN1KMT2AHRH3MAPTCYP1A2
SCHEMBL12096521 0.74 MEN1 (0.56) MEN1KMT2AHRH3MAPTCYP1A2
Dimethylamine SCHEMBL8623187 0.74 MEN1 (0.62) MEN1KMT2AHRH3MAPTNPSR1
SCHEMBL12172299 0.74 KMT2A (0.53) MEN1KMT2AHRH3KDM4ESRD5A2
SCHEMBL12096551 0.74 KMT2A (0.53) MEN1KMT2AHRH3KDM4ESRD5A2
SCHEMBL12096550 0.74 KMT2A (0.53) MEN1KMT2AHRH3KDM4ESRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 MEN1 1830/4885KMT2A 829/4885HRH3 229/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 MEN1 1520/4885KMT2A 1097/4885HRH3 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.